Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

RWDD3 anticorps

Cet anticorps Lapin Polyclonal détecte spécifiquement RWDD3 dans ELISA et IHC. Il présente une réactivité envers Humain.
N° du produit ABIN7118740

Aperçu rapide pour RWDD3 anticorps (ABIN7118740)

Antigène

Voir toutes RWDD3 Anticorps
RWDD3 (RWD Domain Containing 3 (RWDD3))

Reactivité

  • 17
  • 8
  • 7
  • 2
  • 1
Humain

Hôte

  • 16
  • 1
Lapin

Clonalité

  • 17
Polyclonal

Conjugué

  • 12
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp RWDD3 est non-conjugé

Application

  • 17
  • 11
  • 9
  • 7
  • 2
  • 2
ELISA, Immunohistochemistry (IHC)
  • Fonction

    RWDD3 antibody

    Purification

    Immunogen affinity purified

    Pureté

    ≥95 % as determined by SDS-PAGE

    Immunogène

    RWD domain containing 3

    Isotype

    IgG
  • Indications d'application

    IHC: 1:20-1:200

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Avoid repeated freeze / thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    -20°C for 12 months

    Date de péremption

    12 months
  • Antigène

    RWDD3 (RWD Domain Containing 3 (RWDD3))

    Autre désignation

    RWDD3

    Sujet

    Synonyms: RWD domain-containing protein 3|RWD domain-containing sumoylation enhancer (RSUME)|RWDD3|RSUME

    Background: Enhancer of SUMO conjugation. Via its interaction with UBE2I/UBC9, increases SUMO conjugation to proteins by promoting the binding of E1 and E2 enzymes, thioester linkage between SUMO and UBE2I/UBC9 and transfer of SUMO to specific target proteins which include HIF1A, PIAS, NFKBIA, NR3C1 and TOP1. Isoform 1 and isoform 2 positively regulate the NF-kappa-B signaling pathway by enhancing the sumoylation of NF-kappa-B inhibitor alpha(NFKBIA), promoting its stabilization which consequently leads to an increased inhibition of NF-kappa-B transcriptional activity. Isoform 1 and isoform 2 negatively regulate the hypoxia-inducible factor-1 alpha(HIF1A) signaling pathway by increasing the sumoylation of HIF1A, promoting its stabilization, transcriptional activity and the expression of its target gene VEGFA during hypoxia. Isoform 2 promotes the sumoylation and transcriptional activity of the glucocorticoid receptor NR3C1 and enhances the interaction of SUMO1 and NR3C1 with UBE2I/UBC9. Has no effect on ubiquitination.

    ID gène

    25950

    UniProt

    Q9Y3V2
Vous êtes ici:
Chat with us!